Pharmaceutical Business Review
Anonymous User | Login

Qiagen, Linkmed Sign Agreement To Transfer Distribution Rights

Published: 16-Jun-2009

Transaction to increase focus on HLA-related products for use in the high growth area of personalized medicine

Qiagen has entered into an agreement to transfer distribution rights for the Olerup sequence specific primer (SSP) product line and the related assets to Olerup International, a subsidiary of LinkMed.

According to the agreement, Qiagen will continue to have distribution rights to Olerup SSP products that can be used in applications outside transplantation testing.

The agreement also includes options for Qiagen to distribute future Olerup SSP assays for pharmacogenetic applications.

Through the transaction, Qiagen is expecting to increase its focus on the higher growth applications in transplantation testing such as sequencing-based typing, as well as the application of such assays in personalized medicine.

Peer Schatz, CEO of Qiagen, said: The agreement with LinkMed allows us to further execute our corporate strategy and streamline our portfolio.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

World Courier

Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...

WebWise Learning

Turning Information into Working Knowledge ...

Vetter Pharma International

High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...

Valsynthese

Hazardous Chemistry in Safe Hands ...

USB

Products from Affymetrix ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Your IP at Risk in Collaborations!

Free white paper: Ten steps to protect your R&D investment within partnerships. ...

Why, When and How to Conduct 14C Human Studies

Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...

Why CAPA Still Matters

This free white paper explores the needs and effectiveness of correct CAPA control, how to ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly

Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...

USB HotStart-IT for Real Time PCR

USBĀ® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Related Companies

Qiagen N.V.

Qiagen N.V. (Qiagen) provides innovative technologies and products for pre-analytical s ...

Millipore Corporation

Millipore Corporation (Millipore) is a life science company. The company provides innov ...

Applied Biosystems Group

Applied Biosystems Group (Applied Biosystems) is engaged in the development and marketi ...

Sigma-Aldrich Corporation

Sigma-Aldrich Corporation (Sigma-Aldrich) is a Life Science and High Technology company ...

Qiagen N.V.

Qiagen N.V. (Qiagen) provides innovative technologies and products for pre-analytical s ...

Suppliers Product News

World Courier CTSCS Depots Provide Dedicated Storage for GMO Products

In response to growing client demand and based on recently-established international biosafety regulations, World Courier has begun rolling out dedicated storage areas for GMO-derived pharmaceutical products throughout its global investigational drug storage network.

World Courier Triples Clinical Trial Storage Capacity Worldwide with Two New Facilities and Client-Driven Expansion

World Courier expands its GMP-compliant Clinical Trial Supply Chain Services (CTSCS) network, facilitating access to growing pharmaceutical markets in Africa and Australia.

World Courier Achieves Coveted GxP-Compliant Status Worldwide with Focus on GDP, Quality Management

With a fully GxP-compliant transport and supply chain system in place, World Courier meets the most demanding industry requirements for managing time- and temperature-sensitive clinical trial materials used in global studies.

Vetter Dedicates New Facility in Suburban Chicago

The new facility will enable collaboration very early in development process

Pharma Supplier Vetter Shares Pride in Consistent Growth and International Success with Distinguished Visitor Minister zu Guttenberg

Economics and Technology Minister visits global leader's headquarters in southern Germany.

Vetter Packages Success with New Facility

Vetter's new secondary packaging operation allows the company to double its production in half the time.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address